Viridian Therapeutics, Inc./DE Shares Outstanding (Cover Page)
Viridian Therapeutics, Inc./DE (VRDN) had Shares Outstanding (Cover Page) of 113.29 million shares as of 2026-08-03, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-08-03: Entity Common Stock, Shares Outstanding 113.29M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 103.07M shares.
- 2026-02-20: Entity Common Stock, Shares Outstanding 102.21M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 95.44M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 113.29M shares 10-Q · filed 2026-08-06 |
| 2026-05-01 | 103.07M shares 10-Q · filed 2026-05-05 |
| 2026-02-20 | 102.21M shares 10-K · filed 2026-02-26 |
| 2025-10-31 | 95.44M shares 10-Q · filed 2025-11-05 |
| 2025-08-01 | 81.66M shares 10-Q · filed 2025-08-06 |
| 2025-05-01 | 81.59M shares 10-Q · filed 2025-05-06 |
| 2025-02-20 | 81.48M shares 10-K · filed 2025-03-03 |
| 2024-11-07 | 79.21M shares 10-Q · filed 2024-11-12 |
| 2024-08-05 | 63.89M shares 10-Q · filed 2024-08-08 |
| 2024-05-01 | 63.82M shares 10-Q · filed 2024-05-08 |
| 2024-02-22 | 62.77M shares 10-K · filed 2024-02-27 |
| 2023-11-07 | 52.59M shares 10-Q · filed 2023-11-13 |
| 2023-08-07 | 43.67M shares 10-Q · filed 2023-08-08 |
| 2023-05-05 | 43.13M shares 10-Q · filed 2023-05-10 |
| 2023-03-03 | 42.90M shares 10-K · filed 2023-03-09 |
| 2022-11-09 | 40.25M shares 10-Q · filed 2022-11-14 |
| 2022-08-10 | 28.46M shares 10-Q · filed 2022-08-15 |
| 2022-05-09 | 27.93M shares 10-Q · filed 2022-05-13 |
| 2022-03-07 | 25.91M shares 10-K · filed 2022-03-11 |
| 2021-11-03 | 21.72M shares 10-Q · filed 2021-11-05 |
| 2021-08-10 | 9.59M shares 10-Q · filed 2021-08-12 |
| 2021-05-04 | 8.43M shares 10-Q · filed 2021-05-07 |
| 2021-03-18 | 7.23M shares 10-K · filed 2021-03-26 |
| 2020-11-06 | 58.66M shares 10-Q · filed 2020-11-12 |
| 2020-07-29 | 56.61M shares 10-Q · filed 2020-08-05 |
| 2020-05-01 | 53.08M shares 10-Q · filed 2020-05-08 |
| 2020-03-02 | 53.07M shares 10-K · filed 2020-03-13 |
| 2019-11-04 | 31.79M shares 10-Q · filed 2019-11-08 |
| 2019-08-02 | 31.05M shares 10-Q · filed 2019-08-08 |
| 2019-05-02 | 30.93M shares 10-Q · filed 2019-05-09 |
| 2019-03-07 | 30.92M shares 10-K · filed 2019-03-14 |
| 2018-10-31 | 30.84M shares 10-Q · filed 2018-11-07 |
| 2018-08-01 | 30.60M shares 10-Q · filed 2018-08-08 |
| 2018-05-01 | 30.19M shares 10-Q · filed 2018-05-09 |
| 2018-03-12 | 30.17M shares 10-K · filed 2018-03-15 |
| 2017-11-02 | 22.31M shares 10-Q · filed 2017-11-09 |
| 2017-08-03 | 21.48M shares 10-Q · filed 2017-08-11 |
| 2017-05-05 | 21.40M shares 10-Q · filed 2017-05-11 |
| 2017-03-17 | 21.37M shares 10-K · filed 2017-03-24 |
| 2016-10-20 | 10.79M shares 10-Q · filed 2016-10-26 |
| 2016-08-12 | 10.79M shares 10-Q · filed 2016-08-15 |
| 2016-05-06 | 10.71M shares 10-Q · filed 2016-05-16 |
| 2016-03-15 | 10.71M shares 10-K · filed 2016-03-21 |
| 2015-11-06 | 10.64M shares 10-Q · filed 2015-11-13 |
| 2015-08-05 | 7.87M shares 10-Q · filed 2015-08-14 |
| 2015-05-08 | 7.76M shares 10-Q · filed 2015-05-15 |
| 2015-03-15 | 7.50M shares 10-K · filed 2015-03-27 |
| 2014-11-14 | 3.78M shares 10-Q · filed 2014-11-14 |
| 2014-08-14 | 3.78M shares 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |